The FDA has approved Khindivi (hydrocortisone) oral solution as a replacement therapy for children aged 5 years and older with adrenocortical insufficiency. This ready-to-use, berry-flavored liquid ...

Mochizuki developed IUT in the early 2000s and published it across a series of four preprints in 2012. The proof is over 2,000 pages long, and Mochizuki claims it offers a solution to the ABC ...

AstraZeneca has produced some fresh data to back up its blockbuster ambitions for camizestrant, tying the oral SERD to a 56% improvement in progression-free survival (PFS) in a phase 3 breast ...

WATERTOWN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader ...

Credit: Eton. Khindivi is expected to be available the week of June 2, 2025. Khindivi is the first FDA-approved hydrocortisone oral solution. The Food and Drug Administration (FDA) has approved ...

Oral health and heart health are linked in some surprising ways. Gum disease — and the inflammation it causes — can have negative consequences for the heart, studies have found. It may also be ...

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a replacement therapy for ...

KHINDIVI is the only FDA-approved oral solution formulation of hydrocortisone. It comes in a 1mg/ml strength designed to eliminate the need to split or crush tablets, and to offer simple and accurate ...

Credit: Caleb Woods on Unsplash. Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a ...